Pre-planned sales trim Slide (NYSE: SLDE) CEO’s indirect stake

Rhea-AI Filing Summary

Slide Insurance Holdings CEO Bruce Lucas, through entity IIM Holdings II, LLC, reported open‑market sales of Slide common stock under a pre‑planned Rule 10b5‑1 trading plan adopted on November 21, 2025. The entity sold 178,733 shares at a weighted average price of about $18.04 per share on March 26, 2026 and 58,803 shares at about $18.00 per share on March 24, 2026. After these transactions, IIM Holdings II, LLC held 38,657,781 shares indirectly. The filing also lists additional direct and indirect holdings for Lucas and related parties, including spouse and family trusts, and notes that Lucas disclaims beneficial ownership of certain positions except for his pecuniary interest.

Insights

Insider trading and governance analyst

Pre-planned insider sales reduce one indirect stake but remain small.

Slide Insurance Holdings’ CEO-associated entity IIM Holdings II, LLC executed open-market sales totaling 237,536 shares around $18 per share. These trades were made under a pre-arranged Rule 10b5-1 plan adopted on November 21, 2025, indicating they were scheduled in advance rather than timed discretionarily.

Following the sales, the entity still holds 38,657,781 shares, so the dispositions represent a modest fraction of the reported indirect position. The filing also outlines direct holdings and positions in spouse and family trusts, with repeated disclaimers that CEO Bruce Lucas only acknowledges beneficial ownership to the extent of his pecuniary interest.

Overall, the transactions show a net-sell pattern but appear routine in scale and structure, with no derivative exercises and no change to option positions. Future company filings may update how total direct and indirect holdings evolve over time.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lucas Bruce

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FLORIDA 33607

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		S		58,803(1)	D	$18(2)	38,836,514	I	By IIM Holdings II, LLC(3)
Common Stock	03/26/2026		S		178,733(1)	D	$18.04(4)	38,657,781	I	By IIM Holdings II, LLC(3)
Common Stock								1,123,646	D
Common Stock								2,575,837	I	By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
Common Stock								194,201	I	By Spouse(5)
Common Stock								1,529,615(6)	I	By Spouse(7)
Common Stock								1,925,000	I	By Emma Cloonen Irrevocable Trust(8)
Common Stock								1,925,000	I	By Ava Cloonen Irrevocable Trust(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.

2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.90 to $18.07 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

4. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.19 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

5. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

6. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 23,493 shares of common stock between March 24-26, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.90 to $18.19 per share.

7. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

8. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

9. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

	/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider stock transactions did Slide Insurance (SLDE) report for Bruce Lucas?

Slide Insurance reported that an entity controlled by CEO Bruce Lucas, IIM Holdings II, LLC, sold 237,536 shares of common stock in open-market trades around $18 per share under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025.

At what prices were the SLDE shares sold by IIM Holdings II, LLC?

The filing shows weighted average sale prices near $18.00 per share. One transaction averaged $18.04 with individual trades between $17.90 and $18.07, while another averaged $18.00 with trades ranging from $18.00 to $18.19 per Slide Insurance common share.

How many Slide Insurance shares does IIM Holdings II, LLC hold after the sales?

After the reported open-market sales, IIM Holdings II, LLC held 38,657,781 Slide Insurance common shares indirectly. This remaining position suggests the transactions trimmed, but did not substantially reduce, the entity’s reported stake linked to CEO Bruce Lucas.

Were the Slide Insurance insider sales made under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2025. Such plans schedule trades in advance, which typically reduces the significance of timing compared with fully discretionary insider sales.

Does Bruce Lucas personally own all the Slide Insurance shares reported in the Form 4?

No. Many positions are held through entities, a spouse, or family trusts. The filing repeatedly states that Bruce Lucas disclaims beneficial ownership of those securities except to the extent of his pecuniary interest, despite reporting them for Section 16 compliance purposes.

Does the Form 4 show any Slide Insurance option exercises or derivative trades?

No. The derivative section of the filing is empty, and transaction codes relate only to common stock sales. This indicates there were no reported option exercises, warrant conversions, or other derivative transactions for Slide Insurance shares in this Form 4.